AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
. , ranking 287th among listed stocks. The decline came amid mixed market sentiment and sector-specific pressures affecting industrial and healthcare equipment manufacturers.
Recent developments highlighted in the earnings calendar include a strategic pivot toward high-margin service offerings within its MedTech and Life Sciences segments. Management emphasized long-term margin expansion through automation and cost optimization initiatives, though near-term guidance remained cautious due to supply chain volatility in Asia-Pacific markets.
Analysts noted mixed reactions to the company's Q3 2025 outlook, which projected mid-single-digit revenue growth but acknowledged headwinds from raw material price fluctuations. Institutional investors trimmed positions in the stock following a series of downgraded utility forecasts for its Applied and Industrial segment, .
To run this back-test rigorously, I need to make sure we can 1) identify the universe of stocks to rank each day and 2) obtain the daily volume data for every security in that universe. Our current toolset is designed for single-ticker or small sets of tickers; it does not yet support a full cross-sectional ranking of hundreds of stocks on every trading day. To proceed, I need to know how you would like to handle this limitation. Two practical options are: 1) Narrow the universe to a manageable, well-defined list (e.g., the current S&P 500 constituents) and test “buy the top-N (say 50–100) by volume within that list” using equal weights and a 1-day holding period. 2) Approximate the idea with a tradable index/ETF that already represents high-volume stocks (for example, using SPY or another large-cap ETF) to test a simplified version of the strategy.

Hunt down the stocks with explosive trading volume.

Nov.12 2025

Nov.12 2025

Nov.12 2025

Nov.12 2025

Nov.12 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet